459 related articles for article (PubMed ID: 12773046)
1. Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity.
Smith DD; Saha S; Fang G; Schaffert C; Waugh DJ; Zeng W; Toth G; Hulce M; Abel PW
J Med Chem; 2003 Jun; 46(12):2427-35. PubMed ID: 12773046
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity studies on position 14 of human alpha-calcitonin gene-related peptide.
Li J; Matsuura JE; Waugh DJ; Adrian TE; Abel PW; Manning MC; Smith DD
J Med Chem; 1997 Sep; 40(19):3071-6. PubMed ID: 9301670
[TBL] [Abstract][Full Text] [Related]
3. Identification of the key residue of calcitonin gene related peptide (CGRP) 27-37 to obtain antagonists with picomolar affinity at the CGRP receptor.
Lang M; De Pol S; Baldauf C; Hofmann HJ; Reiser O; Beck-Sickinger AG
J Med Chem; 2006 Jan; 49(2):616-24. PubMed ID: 16420047
[TBL] [Abstract][Full Text] [Related]
4. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
5. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
6. Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.
Rorabaugh BR; Scofield MA; Smith DD; Jeffries WB; Abel PW
J Pharmacol Exp Ther; 2001 Dec; 299(3):1086-94. PubMed ID: 11714898
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of novel alpha-Calcitonin Gene-Related Peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors.
Taylor CK; Smith DD; Hulce M; Abel PW
J Pharmacol Exp Ther; 2006 Nov; 319(2):749-57. PubMed ID: 16873605
[TBL] [Abstract][Full Text] [Related]
8. Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors.
Waugh DJ; Bockman CS; Smith DD; Abel PW
J Pharmacol Exp Ther; 1999 Jun; 289(3):1419-26. PubMed ID: 10336535
[TBL] [Abstract][Full Text] [Related]
9. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
10. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.
Rist B; Entzeroth M; Beck-Sickinger AG
J Med Chem; 1998 Jan; 41(1):117-23. PubMed ID: 9438028
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide analogues with aza and indolizidinone amino acid residues reveal conformational requirements for antagonist activity at the human calcitonin gene-related peptide 1 receptor.
Boeglin D; Hamdan FF; Melendez RE; Cluzeau J; Laperriere A; Héroux M; Bouvier M; Lubell WD
J Med Chem; 2007 Mar; 50(6):1401-8. PubMed ID: 17319653
[TBL] [Abstract][Full Text] [Related]
12. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
Peggion E; Mammi S; Schievano E; Schiebler L; Corich M; Rosenblatt M; Chorev M
Biopolymers; 2003 Mar; 68(3):437-57. PubMed ID: 12601801
[TBL] [Abstract][Full Text] [Related]
13. Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains.
Carpenter KA; Schmidt R; von Mentzer B; Haglund U; Roberts E; Walpole C
Biochemistry; 2001 Jul; 40(28):8317-25. PubMed ID: 11444978
[TBL] [Abstract][Full Text] [Related]
14. Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues.
Van Rossum D; Ménard DP; Fournier A; St-Pierre S; Quirion R
J Pharmacol Exp Ther; 1994 May; 269(2):846-53. PubMed ID: 8182554
[TBL] [Abstract][Full Text] [Related]
15. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens.
Wisskirchen FM; Burt RP; Marshall I
Br J Pharmacol; 1998 Apr; 123(8):1673-83. PubMed ID: 9605575
[TBL] [Abstract][Full Text] [Related]
17. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH.
Birkas E; Kertesz I; Toth G; Bakota L; Gulya K; Szucs M
Neuropeptides; 2008 Feb; 42(1):57-67. PubMed ID: 18068762
[TBL] [Abstract][Full Text] [Related]
19. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
[TBL] [Abstract][Full Text] [Related]
20. Solvent effects on coupling yields during rapid solid-phase synthesis of CGRP(8-37) employing in situ neutralization.
Taylor CK; Abel PW; Hulce M; Smith DD
J Pept Res; 2005 Jan; 65(1):84-9. PubMed ID: 15686538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]